Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Catecholamines, such as epinephrine, norepinephrine, and dopamine, are endogenous compounds with well-established roles in cardiovascular physiology. They are potent sympathomimetic agents that increase heart rate, myocardial contractility, and cardiac output by stimulating adrenergic receptors. In clinical practice, catecholamines (or their synthetic analogs) are routinely used as inotropic and vasopressor agents to support the heart in states of acute cardiac "weakness," such as cardiogenic shock, severe heart failure, cardiac arrest, or during anesthesia. Their efficacy and indications are extensively validated by numerous clinical trials and incorporated into international guidelines (e.g., American Heart Association, European Society of Cardiology). Epinephrine and norepinephrine, in particular, are first-line agents for resuscitation and circulatory support in critical care settings. Dopamine is also used, although its indications have narrowed due to risk-benefit considerations. The administration of catecholamines is typically intravenous and requires careful monitoring due to potential adverse effects, including arrhythmias and increased myocardial oxygen demand. In summary, the use of catecholamines to treat or support weakened heart function is based on robust scientific evidence and is a cornerstone of modern emergency and critical care medicine.

More about catecholamine
More about Heart (weakness)

Other ingredients used for Heart (weakness)

Other health conditions supported by catecholamine

Products containing catecholamine